nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0553	0.0817	CbGbCtD
Agomelatine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.052	0.0768	CbGbCtD
Agomelatine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.052	0.0768	CbGbCtD
Agomelatine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0499	0.0736	CbGbCtD
Agomelatine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0471	0.0695	CbGbCtD
Agomelatine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0469	0.0692	CbGbCtD
Agomelatine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0469	0.0692	CbGbCtD
Agomelatine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0424	0.0626	CbGbCtD
Agomelatine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0424	0.0626	CbGbCtD
Agomelatine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0394	0.0582	CbGbCtD
Agomelatine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0366	0.0541	CbGbCtD
Agomelatine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0357	0.0527	CbGbCtD
Agomelatine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0355	0.0525	CbGbCtD
Agomelatine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0321	0.0475	CbGbCtD
Agomelatine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0321	0.0475	CbGbCtD
Agomelatine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0308	0.0455	CbGbCtD
Agomelatine—MTNR1B—retina—acquired immunodeficiency syndrome	0.00765	0.203	CbGeAlD
Agomelatine—MTNR1A—blood—acquired immunodeficiency syndrome	0.00404	0.107	CbGeAlD
Agomelatine—MTNR1A—nervous system—acquired immunodeficiency syndrome	0.00328	0.0871	CbGeAlD
Agomelatine—MTNR1A—central nervous system—acquired immunodeficiency syndrome	0.00316	0.0839	CbGeAlD
Agomelatine—MTNR1A—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00316	0.0492	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00316	0.0492	CbGpPWpGaD
Agomelatine—MTNR1A—brain—acquired immunodeficiency syndrome	0.00251	0.0666	CbGeAlD
Agomelatine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00173	0.046	CbGeAlD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00168	0.0261	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00168	0.0261	CbGpPWpGaD
Agomelatine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00165	0.0437	CbGeAlD
Agomelatine—MTNR1A—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00128	0.0199	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00128	0.0199	CbGpPWpGaD
Agomelatine—HTR2B—skin of body—acquired immunodeficiency syndrome	0.00122	0.0324	CbGeAlD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00102	0.0158	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00102	0.0158	CbGpPWpGaD
Agomelatine—HTR2B—digestive system—acquired immunodeficiency syndrome	0.000976	0.0259	CbGeAlD
Agomelatine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000954	0.0253	CbGeAlD
Agomelatine—HTR2B—blood—acquired immunodeficiency syndrome	0.00093	0.0247	CbGeAlD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00092	0.0143	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00092	0.0143	CbGpPWpGaD
Agomelatine—HTR2B—vagina—acquired immunodeficiency syndrome	0.000862	0.0229	CbGeAlD
Agomelatine—HTR2B—lung—acquired immunodeficiency syndrome	0.000815	0.0216	CbGeAlD
Agomelatine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000804	0.0213	CbGeAlD
Agomelatine—MTNR1B—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000775	0.0121	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000775	0.0121	CbGpPWpGaD
Agomelatine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000774	0.0205	CbGeAlD
Agomelatine—HTR2B—nervous system—acquired immunodeficiency syndrome	0.000755	0.02	CbGeAlD
Agomelatine—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.000727	0.0193	CbGeAlD
Agomelatine—MTNR1A—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000715	0.0111	CbGpPWpGaD
Agomelatine—MTNR1B—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000715	0.0111	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000701	0.0109	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000701	0.0109	CbGpPWpGaD
Agomelatine—MTNR1B—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000672	0.0105	CbGpPWpGaD
Agomelatine—MTNR1A—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000672	0.0105	CbGpPWpGaD
Agomelatine—MTNR1A—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000672	0.0105	CbGpPWpGaD
Agomelatine—MTNR1B—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000672	0.0105	CbGpPWpGaD
Agomelatine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000667	0.0177	CbGeAlD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000664	0.0103	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000664	0.0103	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000656	0.0102	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000656	0.0102	CbGpPWpGaD
Agomelatine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000635	0.0169	CbGeAlD
Agomelatine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000633	0.0168	CbGeAlD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000629	0.00979	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000629	0.00979	CbGpPWpGaD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000624	0.00971	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000624	0.00971	CbGpPWpGaD
Agomelatine—HTR2C—brain—acquired immunodeficiency syndrome	0.000614	0.0163	CbGeAlD
Agomelatine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000603	0.016	CbGeAlD
Agomelatine—HTR2B—brain—acquired immunodeficiency syndrome	0.000577	0.0153	CbGeAlD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000568	0.00885	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000568	0.00885	CbGpPWpGaD
Agomelatine—HTR2B—lymph node—acquired immunodeficiency syndrome	0.000558	0.0148	CbGeAlD
Agomelatine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000557	0.0148	CbGeAlD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000542	0.00844	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000534	0.00832	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000534	0.00832	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000534	0.00832	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000534	0.00832	CbGpPWpGaD
Agomelatine—MTNR1A—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000511	0.00796	CbGpPWpGaD
Agomelatine—MTNR1B—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000511	0.00796	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000479	0.00745	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000479	0.00745	CbGpPWpGaD
Agomelatine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000478	0.00217	CcSEcCtD
Agomelatine—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000478	0.00217	CcSEcCtD
Agomelatine—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.000477	0.00216	CcSEcCtD
Agomelatine—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000476	0.00216	CcSEcCtD
Agomelatine—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000475	0.00215	CcSEcCtD
Agomelatine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000474	0.00215	CcSEcCtD
Agomelatine—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000474	0.00215	CcSEcCtD
Agomelatine—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.000472	0.00214	CcSEcCtD
Agomelatine—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.00047	0.00213	CcSEcCtD
Agomelatine—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000466	0.00211	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000466	0.00211	CcSEcCtD
Agomelatine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000465	0.00211	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000464	0.00211	CcSEcCtD
Agomelatine—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000464	0.0021	CcSEcCtD
Agomelatine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000463	0.0021	CcSEcCtD
Agomelatine—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000462	0.00209	CcSEcCtD
Agomelatine—MTNR1B—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000461	0.00717	CbGpPWpGaD
Agomelatine—MTNR1A—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000461	0.00717	CbGpPWpGaD
Agomelatine—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.00046	0.00209	CcSEcCtD
Agomelatine—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00046	0.00209	CcSEcCtD
Agomelatine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.00046	0.00209	CcSEcCtD
Agomelatine—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.000459	0.00208	CcSEcCtD
Agomelatine—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000459	0.00208	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000458	0.00208	CcSEcCtD
Agomelatine—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000457	0.00207	CcSEcCtD
Agomelatine—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000456	0.00207	CcSEcCtD
Agomelatine—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000454	0.00206	CcSEcCtD
Agomelatine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000454	0.00206	CcSEcCtD
Agomelatine—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000452	0.00205	CcSEcCtD
Agomelatine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000452	0.00205	CcSEcCtD
Agomelatine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000452	0.00205	CcSEcCtD
Agomelatine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000451	0.00205	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000451	0.00204	CcSEcCtD
Agomelatine—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000448	0.00203	CcSEcCtD
Agomelatine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000445	0.00202	CcSEcCtD
Agomelatine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000444	0.00201	CcSEcCtD
Agomelatine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000443	0.00201	CcSEcCtD
Agomelatine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000443	0.00201	CcSEcCtD
Agomelatine—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000441	0.002	CcSEcCtD
Agomelatine—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00044	0.002	CcSEcCtD
Agomelatine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00044	0.002	CcSEcCtD
Agomelatine—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00044	0.002	CcSEcCtD
Agomelatine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000438	0.00199	CcSEcCtD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000437	0.00681	CbGpPWpGaD
Agomelatine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000433	0.00197	CcSEcCtD
Agomelatine—MTNR1B—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000433	0.00674	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000433	0.00674	CbGpPWpGaD
Agomelatine—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000433	0.00196	CcSEcCtD
Agomelatine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000432	0.00196	CcSEcCtD
Agomelatine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000431	0.00196	CcSEcCtD
Agomelatine—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.00195	CcSEcCtD
Agomelatine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000429	0.00194	CcSEcCtD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000428	0.00666	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000428	0.00666	CbGpPWpGaD
Agomelatine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000427	0.00194	CcSEcCtD
Agomelatine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000427	0.00194	CcSEcCtD
Agomelatine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000427	0.00193	CcSEcCtD
Agomelatine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000426	0.00193	CcSEcCtD
Agomelatine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000426	0.00193	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000426	0.00193	CcSEcCtD
Agomelatine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000425	0.00193	CcSEcCtD
Agomelatine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000424	0.00192	CcSEcCtD
Agomelatine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000423	0.00192	CcSEcCtD
Agomelatine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000422	0.00192	CcSEcCtD
Agomelatine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000421	0.00191	CcSEcCtD
Agomelatine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00042	0.00191	CcSEcCtD
Agomelatine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00042	0.0019	CcSEcCtD
Agomelatine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00042	0.0019	CcSEcCtD
Agomelatine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000419	0.0019	CcSEcCtD
Agomelatine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000419	0.0019	CcSEcCtD
Agomelatine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000417	0.00189	CcSEcCtD
Agomelatine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000416	0.00189	CcSEcCtD
Agomelatine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000415	0.00188	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000413	0.00643	CbGpPWpGaD
Agomelatine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000412	0.00187	CcSEcCtD
Agomelatine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000409	0.00186	CcSEcCtD
Agomelatine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000409	0.00185	CcSEcCtD
Agomelatine—MTNR1A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000407	0.00634	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000407	0.00634	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000407	0.00634	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000407	0.00634	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000407	0.00633	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000407	0.00633	CbGpPWpGaD
Agomelatine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000404	0.00183	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000404	0.00183	CcSEcCtD
Agomelatine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000403	0.00183	CcSEcCtD
Agomelatine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000403	0.00183	CcSEcCtD
Agomelatine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000402	0.00182	CcSEcCtD
Agomelatine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000401	0.00182	CcSEcCtD
Agomelatine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.0004	0.00182	CcSEcCtD
Agomelatine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.0004	0.00181	CcSEcCtD
Agomelatine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.0004	0.00181	CcSEcCtD
Agomelatine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000399	0.00181	CcSEcCtD
Agomelatine—MTNR1B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000398	0.00619	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000398	0.00619	CbGpPWpGaD
Agomelatine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000397	0.0018	CcSEcCtD
Agomelatine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000396	0.00179	CcSEcCtD
Agomelatine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000394	0.00179	CcSEcCtD
Agomelatine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000394	0.00179	CcSEcCtD
Agomelatine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000394	0.00179	CcSEcCtD
Agomelatine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000393	0.00178	CcSEcCtD
Agomelatine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000391	0.00177	CcSEcCtD
Agomelatine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00039	0.00177	CcSEcCtD
Agomelatine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000388	0.00176	CcSEcCtD
Agomelatine—MTNR1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000388	0.00604	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000388	0.00604	CbGpPWpGaD
Agomelatine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000387	0.00176	CcSEcCtD
Agomelatine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000387	0.00175	CcSEcCtD
Agomelatine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000386	0.00175	CcSEcCtD
Agomelatine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000385	0.00175	CcSEcCtD
Agomelatine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000383	0.00174	CcSEcCtD
Agomelatine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000383	0.00174	CcSEcCtD
Agomelatine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000382	0.00173	CcSEcCtD
Agomelatine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000382	0.00173	CcSEcCtD
Agomelatine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000382	0.00173	CcSEcCtD
Agomelatine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000381	0.00173	CcSEcCtD
Agomelatine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000381	0.00173	CcSEcCtD
Agomelatine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00038	0.00172	CcSEcCtD
Agomelatine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00038	0.00172	CcSEcCtD
Agomelatine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000378	0.00171	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000377	0.00171	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000375	0.0017	CcSEcCtD
Agomelatine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000375	0.0017	CcSEcCtD
Agomelatine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000375	0.0017	CcSEcCtD
Agomelatine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000374	0.00169	CcSEcCtD
Agomelatine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000372	0.00169	CcSEcCtD
Agomelatine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000372	0.00169	CcSEcCtD
Agomelatine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000371	0.00168	CcSEcCtD
Agomelatine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.00168	CcSEcCtD
Agomelatine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00037	0.00168	CcSEcCtD
Agomelatine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000369	0.00167	CcSEcCtD
Agomelatine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000369	0.00167	CcSEcCtD
Agomelatine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000368	0.00167	CcSEcCtD
Agomelatine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000368	0.00167	CcSEcCtD
Agomelatine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000367	0.00167	CcSEcCtD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000366	0.0057	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000366	0.0057	CbGpPWpGaD
Agomelatine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000365	0.00166	CcSEcCtD
Agomelatine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000364	0.00165	CcSEcCtD
Agomelatine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000363	0.00164	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000362	0.00164	CcSEcCtD
Agomelatine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000362	0.00164	CcSEcCtD
Agomelatine—MTNR1B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00036	0.0056	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00036	0.0056	CbGpPWpGaD
Agomelatine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.00162	CcSEcCtD
Agomelatine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000357	0.00162	CcSEcCtD
Agomelatine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000357	0.00162	CcSEcCtD
Agomelatine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000356	0.00161	CcSEcCtD
Agomelatine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000356	0.00161	CcSEcCtD
Agomelatine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000356	0.00161	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000355	0.00161	CcSEcCtD
Agomelatine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000354	0.00161	CcSEcCtD
Agomelatine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000354	0.00161	CcSEcCtD
Agomelatine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000353	0.0016	CcSEcCtD
Agomelatine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000353	0.0016	CcSEcCtD
Agomelatine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000351	0.00159	CcSEcCtD
Agomelatine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000351	0.00159	CcSEcCtD
Agomelatine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00035	0.00159	CcSEcCtD
Agomelatine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000349	0.00159	CcSEcCtD
Agomelatine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000349	0.00158	CcSEcCtD
Agomelatine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.00158	CcSEcCtD
Agomelatine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000347	0.00157	CcSEcCtD
Agomelatine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000346	0.00157	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000346	0.00157	CcSEcCtD
Agomelatine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000345	0.00157	CcSEcCtD
Agomelatine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000344	0.00156	CcSEcCtD
Agomelatine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000343	0.00156	CcSEcCtD
Agomelatine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000343	0.00156	CcSEcCtD
Agomelatine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000342	0.00155	CcSEcCtD
Agomelatine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.00154	CcSEcCtD
Agomelatine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00034	0.00154	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000339	0.00154	CcSEcCtD
Agomelatine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000339	0.00154	CcSEcCtD
Agomelatine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000338	0.00153	CcSEcCtD
Agomelatine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000338	0.00153	CcSEcCtD
Agomelatine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000337	0.00153	CcSEcCtD
Agomelatine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000337	0.00153	CcSEcCtD
Agomelatine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000336	0.00152	CcSEcCtD
Agomelatine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000336	0.00152	CcSEcCtD
Agomelatine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000335	0.00152	CcSEcCtD
Agomelatine—HTR2C—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000333	0.00519	CbGpPWpGaD
Agomelatine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000332	0.00151	CcSEcCtD
Agomelatine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.0015	CcSEcCtD
Agomelatine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000331	0.0015	CcSEcCtD
Agomelatine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000331	0.0015	CcSEcCtD
Agomelatine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000329	0.00149	CcSEcCtD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000328	0.00511	CbGpPWpGaD
Agomelatine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000327	0.00148	CcSEcCtD
Agomelatine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000326	0.00148	CcSEcCtD
Agomelatine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000326	0.00148	CcSEcCtD
Agomelatine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000325	0.00147	CcSEcCtD
Agomelatine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000324	0.00147	CcSEcCtD
Agomelatine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000323	0.00147	CcSEcCtD
Agomelatine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000323	0.00146	CcSEcCtD
Agomelatine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000321	0.00146	CcSEcCtD
Agomelatine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000321	0.00145	CcSEcCtD
Agomelatine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.00145	CcSEcCtD
Agomelatine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00032	0.00145	CcSEcCtD
Agomelatine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00032	0.00145	CcSEcCtD
Agomelatine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000316	0.00144	CcSEcCtD
Agomelatine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000315	0.00143	CcSEcCtD
Agomelatine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000314	0.00142	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.00142	CcSEcCtD
Agomelatine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000313	0.00142	CcSEcCtD
Agomelatine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000312	0.00142	CcSEcCtD
Agomelatine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000312	0.00142	CcSEcCtD
Agomelatine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000311	0.00141	CcSEcCtD
Agomelatine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000311	0.00141	CcSEcCtD
Agomelatine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000311	0.00141	CcSEcCtD
Agomelatine—MTNR1B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00031	0.00482	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00031	0.00482	CbGpPWpGaD
Agomelatine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000309	0.0014	CcSEcCtD
Agomelatine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.0014	CcSEcCtD
Agomelatine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000308	0.0014	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.00137	CcSEcCtD
Agomelatine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00137	CcSEcCtD
Agomelatine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.00137	CcSEcCtD
Agomelatine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.0003	0.00136	CcSEcCtD
Agomelatine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000299	0.00136	CcSEcCtD
Agomelatine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000298	0.00135	CcSEcCtD
Agomelatine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000297	0.00135	CcSEcCtD
Agomelatine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000297	0.00135	CcSEcCtD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000297	0.00462	CbGpPWpGaD
Agomelatine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000297	0.00135	CcSEcCtD
Agomelatine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000295	0.00134	CcSEcCtD
Agomelatine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.00133	CcSEcCtD
Agomelatine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000293	0.00133	CcSEcCtD
Agomelatine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000291	0.00132	CcSEcCtD
Agomelatine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.00131	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.00131	CcSEcCtD
Agomelatine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.00131	CcSEcCtD
Agomelatine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000288	0.0013	CcSEcCtD
Agomelatine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.0013	CcSEcCtD
Agomelatine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000286	0.0013	CcSEcCtD
Agomelatine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000285	0.00129	CcSEcCtD
Agomelatine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00128	CcSEcCtD
Agomelatine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000281	0.00127	CcSEcCtD
Agomelatine—MTNR1B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000279	0.00434	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000279	0.00434	CbGpPWpGaD
Agomelatine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.00126	CcSEcCtD
Agomelatine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.00126	CcSEcCtD
Agomelatine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000278	0.00126	CcSEcCtD
Agomelatine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000277	0.00125	CcSEcCtD
Agomelatine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000277	0.00125	CcSEcCtD
Agomelatine—Naproxen—ALB—acquired immunodeficiency syndrome	0.000276	0.553	CrCbGaD
Agomelatine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000273	0.00124	CcSEcCtD
Agomelatine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000272	0.00124	CcSEcCtD
Agomelatine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.00123	CcSEcCtD
Agomelatine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000269	0.00122	CcSEcCtD
Agomelatine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.0012	CcSEcCtD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000265	0.00413	CbGpPWpGaD
Agomelatine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.0012	CcSEcCtD
Agomelatine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000261	0.00118	CcSEcCtD
Agomelatine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.00118	CcSEcCtD
Agomelatine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.00118	CcSEcCtD
Agomelatine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000258	0.00117	CcSEcCtD
Agomelatine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000257	0.00117	CcSEcCtD
Agomelatine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.00117	CcSEcCtD
Agomelatine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00114	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00025	0.00389	CbGpPWpGaD
Agomelatine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00025	0.00113	CcSEcCtD
Agomelatine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.00113	CcSEcCtD
Agomelatine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.00112	CcSEcCtD
Agomelatine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000246	0.00112	CcSEcCtD
Agomelatine—MTNR1B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000246	0.00382	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000246	0.00382	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000245	0.00381	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000245	0.00381	CbGpPWpGaD
Agomelatine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.00111	CcSEcCtD
Agomelatine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00109	CcSEcCtD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00024	0.00373	CbGpPWpGaD
Agomelatine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.00109	CcSEcCtD
Agomelatine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.00109	CcSEcCtD
Agomelatine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.00107	CcSEcCtD
Agomelatine—MTNR1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000235	0.00366	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000235	0.00366	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000235	0.00366	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000235	0.00366	CbGpPWpGaD
Agomelatine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.00106	CcSEcCtD
Agomelatine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00105	CcSEcCtD
Agomelatine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.00105	CcSEcCtD
Agomelatine—MTNR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00023	0.00358	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00023	0.00358	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00023	0.00358	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00023	0.00358	CbGpPWpGaD
Agomelatine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.00104	CcSEcCtD
Agomelatine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.00103	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000226	0.00352	CbGpPWpGaD
Agomelatine—Indomethacin—ALB—acquired immunodeficiency syndrome	0.000223	0.448	CrCbGaD
Agomelatine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.00101	CcSEcCtD
Agomelatine—MTNR1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000222	0.00346	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000222	0.00346	CbGpPWpGaD
Agomelatine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.001	CcSEcCtD
Agomelatine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000994	CcSEcCtD
Agomelatine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.000979	CcSEcCtD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000214	0.00333	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000212	0.00331	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000212	0.00331	CbGpPWpGaD
Agomelatine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000963	CcSEcCtD
Agomelatine—HTR2B—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000212	0.0033	CbGpPWpGaD
Agomelatine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000948	CcSEcCtD
Agomelatine—MTNR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000209	0.00325	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000209	0.00325	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000209	0.00325	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000209	0.00325	CbGpPWpGaD
Agomelatine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000943	CcSEcCtD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000203	0.00316	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000202	0.00314	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000201	0.00314	CbGpPWpGaD
Agomelatine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000899	CcSEcCtD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000184	0.00286	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000182	0.00284	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000177	0.00276	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000177	0.00276	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000175	0.00272	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000175	0.00272	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000173	0.00269	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000173	0.00269	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000173	0.00269	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000172	0.00268	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000172	0.00268	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000171	0.00266	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000164	0.00255	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000162	0.00253	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000159	0.00247	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000159	0.00247	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000158	0.00245	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000158	0.00245	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000157	0.00244	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000157	0.00244	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000155	0.00241	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000148	0.0023	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000145	0.00226	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000145	0.00226	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000143	0.00223	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000143	0.00223	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00014	0.00218	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000139	0.00217	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000139	0.00217	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000138	0.00215	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000131	0.00205	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000131	0.00205	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000131	0.00204	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000131	0.00204	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000131	0.00204	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000128	0.002	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000125	0.00195	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000125	0.00195	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000125	0.00194	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000123	0.00192	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000123	0.00192	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000123	0.00192	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000123	0.00192	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000118	0.00184	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000116	0.00181	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000113	0.00176	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000111	0.00174	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000111	0.00173	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000106	0.00165	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000106	0.00165	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000106	0.00165	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000105	0.00163	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000104	0.00161	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000101	0.00157	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.0001	0.00156	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	9.54e-05	0.00149	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.39e-05	0.00146	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.39e-05	0.00146	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	9.37e-05	0.00146	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.25e-05	0.00144	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.25e-05	0.00144	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.11e-05	0.00142	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.11e-05	0.00142	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	9.01e-05	0.0014	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.96e-05	0.0014	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.46e-05	0.00132	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.46e-05	0.00132	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.27e-05	0.00129	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.27e-05	0.00129	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	8.12e-05	0.00126	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	8.12e-05	0.00126	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	8.06e-05	0.00126	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.93e-05	0.00123	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.9e-05	0.00123	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.58e-05	0.00118	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.58e-05	0.00118	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.43e-05	0.00116	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.43e-05	0.00116	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	7.27e-05	0.00113	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	7.17e-05	0.00112	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.86e-05	0.00107	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6.74e-05	0.00105	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6.74e-05	0.00105	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	6.4e-05	0.000996	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	6.37e-05	0.000992	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.12e-05	0.000952	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.12e-05	0.000952	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	5.99e-05	0.000933	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	5.99e-05	0.000933	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.79e-05	0.000901	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.65e-05	0.000879	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.56e-05	0.000866	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.53e-05	0.000861	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	5.49e-05	0.000855	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.44e-05	0.000847	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.44e-05	0.000847	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	5.42e-05	0.000844	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.13e-05	0.000799	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5.09e-05	0.000792	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.05e-05	0.000787	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.89e-05	0.000761	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.89e-05	0.000761	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.86e-05	0.000757	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.86e-05	0.000757	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	4.69e-05	0.000731	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.68e-05	0.000729	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	4.67e-05	0.000727	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.62e-05	0.000719	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.56e-05	0.00071	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.49e-05	0.000699	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	4.38e-05	0.000681	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.24e-05	0.00066	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.14e-05	0.000644	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.11e-05	0.000639	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.08e-05	0.000635	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.99e-05	0.000621	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.98e-05	0.00062	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.98e-05	0.00062	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.78e-05	0.000588	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.73e-05	0.00058	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.42e-05	0.000532	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.21e-05	0.0005	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.21e-05	0.0005	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.03e-05	0.000472	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.98e-05	0.000465	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.94e-05	0.000458	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.87e-05	0.000447	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.87e-05	0.000447	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.73e-05	0.000425	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.67e-05	0.000416	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.44e-05	0.000381	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.41e-05	0.000375	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.37e-05	0.000369	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.2e-05	0.000343	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.15e-05	0.000335	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.15e-05	0.000335	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.84e-05	0.000286	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.58e-05	0.000246	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.57e-05	0.000244	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.27e-05	0.000198	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.27e-05	0.000197	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	9.58e-06	0.000149	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.27e-06	0.000144	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	8.19e-06	0.000127	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.48e-06	0.000116	CbGpPWpGaD
